7th Edition of Global Conference on Addiction Medicine, Behavioral Health and Psychiatry
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 7th Edition of Global Conference on Addiction Medicine, Behavioral Health and Psychiatry — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
7th Edition of Global Conference on Addiction Medicine, Behavioral Health and Psychiatry
Dates: October 19–21, 2026
Venue: Hilton Boston/Woburn, 2 Forbes Road, Woburn, Massachusetts, 01801, USA
Event Type: Hybrid (In-person & Virtual Participation Available)
About the Conference
The 7th Edition of the Global Conference on Addiction Medicine, Behavioral Health and Psychiatry (GAB 2026) is a premier hybrid event designed to foster collaboration, innovation, and knowledge exchange among professionals in psychiatry, addiction medicine, and behavioral health. Themed "Innovating Pathways: Transforming Addiction Medicine and Behavioral Health", this conference brings together a diverse global audience to address emerging trends, research advancements, and interdisciplinary approaches in mental health care.
Target Audience
- Psychotherapists and Psychiatrists
- Addiction Specialists and Recovery Coordinators
- Clinical Psychologists and Counselors
- Neuroscientists and Biomedical Researchers
- Healthcare Policy Makers and Administrators
- Mental Health Advocates and Community Program Directors
- Academic Institutions and Training Program Leaders
- Pharmaceutical and Digital Health Industry Representatives
Key Highlights
GAB 2026 offers a comprehensive platform for professionals to:
- Engage with keynote speakers, panel discussions, and interactive workshops.
- Explore advancements in diagnostics, treatment strategies, and integrative care models.
- Participate in oral and poster presentations showcasing cutting-edge research.
- Network with global experts, policymakers, and industry innovators.
- Access collaborative sessions focused on translating research into practical solutions.
Scientific Sessions
- Substance Use Disorders: Prevention, Diagnosis, and Treatment
- Opioid Crisis: Public Health Strategies and Interventions
- Pharmacotherapy and Medication-Assisted Treatment
- Major Depressive Disorder and Treatment Innovations
- Psychedelics and Alternative Therapies in Psychiatry
- Anxiety Disorders: Advances in Therapy and Research
- Trauma and Post-Traumatic Stress Disorder (PTSD)
- Suicide Prevention Strategies and Crisis Intervention
- Digital Mental Health and Telepsychiatry
- Adolescent and Youth Mental Health Challenges
Important Dates
First Round of Abstract Submission Closes: June 27, 2026
Early Bird Registration Closes: June 30, 2026
Contact Information
Email: [email protected]
Phone: +1 (702) 988-2320
WhatsApp: +1 (540) 709-1879
Registration & Participation
Register for in-person or virtual participation to access the full scientific program, networking opportunities, and exclusive content. Visit the official website for registration details and abstract submission guidelines: Official Conference Website.
Data sheet
7th Edition of Global Conference on Addiction Medicine, Behavioral Health and Psychiatry – Event Attendee & Buyer Profile Analysis
Event date: October 19–21, 2026
Location: Hilton Boston/Woburn, Woburn, Massachusetts, USA
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 7th Edition of Global Conference on Addiction Medicine, Behavioral Health and Psychiatry (GAB 2026) |
| Event Date | October 19–21, 2026 |
| Event Status | Upcoming |
| Venue | Hilton Boston/Woburn |
| City | Woburn |
| State / Region | Massachusetts |
| Country | USA |
| Organizer | Magnus Group |
| Official Event Website | addiction-behavioral-conferences.magnusgroup.org |
| Event Type | Hybrid conference (in-person and virtual participation) |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness; Science & Research; Education & Training |
| Audience Reach | Global, with U.S. in-person hub and virtual international access |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for headcount; official website confirms event dates, venue, hybrid format, topic scope, and attendee profile, but not current-year volume metrics. |
| Main Purpose of Event | Professional education, research exchange, interdisciplinary collaboration, networking, and discussion of innovations in addiction medicine, behavioral health, psychiatry, diagnostics, treatment strategies, and digital mental health. |
About the Event
The 7th Edition of Global Conference on Addiction Medicine, Behavioral Health and Psychiatry (GAB 2026) is an upcoming hybrid medical conference scheduled for October 19–21, 2026, with in-person activity at Hilton Boston/Woburn in Massachusetts and virtual access for remote participants. Based on the official event website, the conference is positioned around the theme “Innovating Pathways: Transforming Addiction Medicine and Behavioral Health” and is designed to convene psychiatrists, psychologists, addiction specialists, neuroscientists, clinicians, researchers, policymakers, healthcare professionals, and industry experts.
From a commercial and attendee-intelligence perspective, the event matters because it attracts decision-influencing clinical, academic, research, program, and health-system stakeholders involved in mental health treatment, addiction care delivery, telepsychiatry, diagnostics, public-health strategy, and behavioral-health innovation. It is particularly relevant for organizations selling clinical technology, digital therapeutics, pharmaceuticals, behavioral-health services, research partnerships, training, continuing education, telehealth, analytics, care coordination, and institutional collaboration solutions.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Psychiatrists and addiction medicine physicians | Hospitals, psychiatric practices, addiction treatment centers, academic medical centers | Clinical decision-makers, treatment adopters, advisory influencers | High relevance for pharmaceuticals, diagnostics, clinical software, digital therapeutics, and continuing education |
| Clinical psychologists, counselors, therapists | Behavioral health clinics, counseling networks, community mental health providers | Service adopters, referral influencers, program-level evaluators | Relevant for therapy tools, assessments, telehealth platforms, patient engagement solutions, training services |
| Recovery coordinators and addiction specialists | Rehabilitation centers, outpatient recovery programs, substance-use treatment providers | Operational buyers, care-pathway influencers, vendor evaluators | Relevant for treatment workflow tools, patient monitoring, care coordination, recovery support services |
| Neuroscientists and biomedical researchers | Universities, research institutes, laboratories, academic consortia | Research buyers, grant collaborators, innovation evaluators | Relevant for research technology, laboratory services, data platforms, publishing and collaboration tools |
| Healthcare administrators and program directors | Health systems, treatment networks, behavioral health organizations, nonprofit care providers | Budget holders, implementation sponsors, partnership approvers | High relevance for enterprise software, care delivery services, staffing, training, analytics, reimbursement support |
| Healthcare policymakers and public-health stakeholders | Government agencies, public-health departments, health policy bodies | Policy influence, grant allocation, program evaluation, public-sector procurement influence | Relevant for public-health solutions, prevention programs, data reporting, community intervention models |
| Academic institutions and training leaders | Medical schools, psychology departments, residency and fellowship programs | Curriculum buyers, research partners, institutional influencers | Relevant for education technology, simulation, certification, accreditation, publishing and research support |
| Digital health and industry representatives | Telepsychiatry vendors, pharma companies, medical device and mental health technology firms | Partnership builders, sponsors, channel collaborators | Relevant for co-selling, distribution partnerships, scientific visibility, and clinical-market access |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Woburn / Greater Boston | Local clinicians, nearby hospitals, universities, research centers, behavioral health providers | High | Boston-area medical, academic, and biotech ecosystem increases relevance for clinical and research attendees |
| Massachusetts | Statewide mental health providers, public-health stakeholders, academic programs, treatment networks | High | Strong healthcare and higher-education base supports regional participation |
| Northeast U.S. | Attendees from New York, Connecticut, Rhode Island, New Hampshire, Vermont, Maine, New Jersey, Pennsylvania | High | Practical travel corridor for hospital systems, universities, community treatment providers, and policy attendees |
| United States national reach | Clinicians, researchers, healthcare professionals, policymakers, and industry experts from across the U.S. | Medium to High | Official site positions the event as a global conference and U.S.-hosted hybrid meeting |
| International / Virtual | Global remote audience of researchers, clinicians, and industry professionals | Medium | Official website explicitly offers virtual participation from anywhere, expanding international access |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website describes the event as bringing together professionals from around the world and explicitly supports virtual participation from anywhere. |
| National | Secondary U.S. reach | The Boston/Woburn venue provides a strong in-person U.S. anchor for hospitals, universities, treatment providers, and health systems. |
| Regional | Operationally relevant | The Greater Boston and Northeast corridor is likely to contribute a meaningful in-person attendance share due to proximity and concentration of medical institutions. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Current-year buyer, attendee, speaker-organization, exhibitor, or sponsor company list | Not publicly confirmed in reviewed source material | The official event page reviewed confirms event details, audience profile, and program themes, but does not provide a verifiable current-year organization list in the supplied material. | N/A | N/A | Confirmed information unavailable |
| Use case note | Lead generation guidance | This event is suitable for B2B attendee-list building only if additional official sources such as speaker pages, scientific program, sponsor listings, or past-event participant directories are verified before outreach. | N/A | Medical directors, psychiatry chairs, behavioral health program leaders, telehealth directors, research directors | Assessment note |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Medical Director, Behavioral Health | Clinical Leadership | Director / Executive | Evaluates treatment models, care pathways, and clinical technology adoption |
| 2 | Chief Medical Officer | Executive Leadership | C-Level | High-value decision-maker for clinical strategy, partnerships, and institutional adoption |
| 3 | Director of Psychiatry | Psychiatry / Mental Health Services | Director | Influences treatment systems, education, staffing, and vendor selection |
| 4 | Director of Behavioral Health Services | Operations / Clinical Programs | Director | Oversees implementation, care delivery outcomes, and service optimization |
| 5 | Addiction Medicine Specialist / Program Lead | Clinical Programs | Manager / Director / Physician Leader | Core audience segment for treatment innovation and care coordination offerings |
| 6 | Clinical Research Director | Research | Director | Important for trials, data platforms, collaborative research, and innovation partnerships |
| 7 | Telepsychiatry Director / Digital Health Director | Digital Health / Innovation | Director | Relevant due to conference emphasis on digital mental health and telepsychiatry |
| 8 | Program Manager, Community Mental Health | Programs / Outreach | Manager | Useful target for community intervention, prevention, and public-health services |
| 9 | Department Chair, Psychiatry / Psychology | Academic Leadership | Executive / Director | Important for academic partnerships, training, and thought leadership outreach |
| 10 | Healthcare Policy Advisor / Public Health Director | Government / Policy | Director / Executive | Relevant for prevention programs, grant initiatives, public-health deployment, and policy-linked services |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core institutional audience for behavioral health and psychiatry services | Clinical solutions, telehealth, care coordination, diagnostics, workforce training |
| 2 | Mental Health Care | Direct fit for psychotherapy, counseling, and psychiatric service providers | Therapy platforms, treatment support, patient engagement, referral tools |
| 3 | Medical Practice | Relevant for specialty clinics and physician-led addiction and psychiatry practices | Clinical products, EHR-adjacent tools, appointment and compliance support |
| 4 | Pharmaceuticals | Medication-assisted treatment and psychiatric therapeutics are central topic areas | Scientific outreach, partnerships, education sponsorships, therapeutic adoption |
| 5 | Medical Devices | Relevant where diagnostics, monitoring, or neurobehavioral tools are marketed | Assessment devices, clinical monitoring, digital therapeutics support hardware |
| 6 | Biotechnology | Supports translational neuroscience, biomarker, and research-driven innovation participation | Research collaborations, biomarker studies, trial-support technologies |
| 7 | Information Technology & Services | Strong fit for telepsychiatry, analytics, interoperability, and digital care tools | Telehealth platforms, data integration, workflow automation, patient experience tools |
| 8 | Computer Software | Relevant for mental health SaaS and clinician-support applications | Behavioral health software, patient assessments, documentation, remote care |
| 9 | Research | Official attendee profile includes researchers and neuroscientists | Academic partnerships, data services, publishing, laboratory support |
| 10 | Higher Education | Academic institutions and training leaders are listed in the target audience | Curriculum support, research collaboration, recruitment, academic tools |
| 11 | Government Administration | Public-health and policy stakeholders are explicitly referenced | Community programs, grant-funded services, policy implementation support |
| 12 | Health, Wellness & Fitness | Relevant for preventive, recovery, and patient well-being programs linked to mental health | Holistic care programs, wellness engagement, recovery support ecosystems |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Reviewed official event website extract | No attendee count found in supplied official materials |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Reviewed official event website extract | No exhibitor directory identified in supplied material |
| Buyer count | Not publicly confirmed | Unconfirmed | Reviewed official event website extract | Conference is education-led rather than buyer-program-led in the reviewed source |
| Speaker count | Not publicly confirmed in supplied extract | Unconfirmed | Official website navigation shows a speakers section | Speaker names and counts were not available in the reviewed text |
| Sponsor count | Not publicly confirmed | Unconfirmed | Reviewed official event website extract | No sponsor listing found in supplied material |
| Historical attendance | Historical attendance not verified from supplied official materials | Historical / prior-year evidence unavailable in this review | Past event links listed on official website navigation | Past-edition quantitative metrics should be verified separately before use in sales collateral |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Addiction medicine | Improved treatment pathways, medication support, relapse prevention, recovery coordination | Clinical demonstrations, treatment outcome discussions, referral network partnerships | MAT support tools, care coordination software, patient monitoring, recovery programs |
| Behavioral health services | Scalable therapy access, patient engagement, integrated care models | Operational workflow discussions, network expansion, service model partnerships | Behavioral health platforms, counseling support, digital triage, patient communications |
| Psychiatry treatment innovation | Evidence-based diagnostics, treatment personalization, therapy optimization | Scientific exchange, pilot studies, formulary and protocol influence | Diagnostics, clinical decision support, pharmaceuticals, specialty care tools |
| Digital mental health and telepsychiatry | Remote care delivery, patient access, clinician efficiency, compliance | Technology evaluations, integration talks, pilot deployments | Telehealth software, virtual care platforms, analytics, scheduling, secure messaging |
| Neurobehavioral research | Data quality, collaboration, translational pathways, study support | Research partnership development, grant-aligned collaboration, publication support | Research platforms, data services, laboratory support, academic collaboration tools |
| Public-health strategy | Crisis intervention, prevention programs, community response models | Policy dialogue, grant-linked engagement, public-sector program design | Population health tools, intervention services, reporting systems, training initiatives |
| Education and professional development | Continuing education, workforce capability building, interdisciplinary learning | Curriculum partnerships, workshop sponsorships, certification-related engagement | Training platforms, CME support, simulation, content and publishing services |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The event attracts clinically and academically relevant professionals in psychiatry, addiction medicine, behavioral health, and digital mental health. |
| Decision-maker availability | Medium to High | Director-level, physician-leader, academic-leader, and program-leader personas are likely, although a named attendee list was not verified. |
| Data collection potential | Medium | Useful for segment-building and persona targeting, but official organization-level participation data in the reviewed material is limited. |
| Apollo targeting potential | High | Behavioral health, hospital, medical practice, pharma, and research targets can be efficiently modeled in Apollo using title, department, and geography filters. |
| Geographic targeting potential | High | Strong opportunity to prioritize Greater Boston, Massachusetts, Northeast U.S., and broader U.S. healthcare ecosystems, plus selected global virtual audiences. |
| Best outreach approach | High-value educational and clinical relevance messaging | Position around evidence, outcomes, workflow improvement, patient access, care quality, and collaboration rather than generic sales messaging. |
| Overall lead quality | High | Strong strategic fit for healthcare, medtech, digital health, research, and education vendors targeting mental health ecosystems. |
| Best use case | Persona-based B2B outreach and account-based prospecting | Best suited for building ideal attendee profiles and high-fit account lists rather than relying on a verified attendee list from the reviewed materials. |
| Limitations / risks | Medium | Current-year attendee counts, speaker organizations, sponsor names, and buyer organizations were not publicly confirmed in the supplied official content. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Mental Health Care; Medical Practice; Pharmaceuticals; Medical Devices; Biotechnology; Research; Higher Education; Government Administration; Information Technology & Services; Computer Software; Health, Wellness & Fitness | Capture the most relevant clinical, academic, public-health, and digital health account base |
| Departments | Medical & Health; Operations; Research; Information Technology; Education; Program Management; Executive | Map outreach to care delivery, innovation, administration, and research functions |
| Seniority | C-Level; VP; Director; Head; Manager | Focus on budget holders and implementation influencers |
| Job titles | Chief Medical Officer; Medical Director; Director of Behavioral Health; Director of Psychiatry; Psychiatry Chair; Clinical Director; Addiction Medicine Director; Telepsychiatry Director; Research Director; Program Director; Behavioral Health Operations Director; Public Health Director | Reach the most event-relevant functional buyers and influencers |
| Geography | Massachusetts; Greater Boston; Northeast U.S.; United States; selected international English-speaking healthcare markets | Prioritize likely in-person and hybrid-engaged regions first |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Covers specialty clinics through large health systems, universities, and enterprise suppliers |
| Keywords | behavioral health, addiction medicine, psychiatry, mental health, substance use disorder, opioid treatment, telepsychiatry, recovery, community mental health, neuroscience, psychiatric care, digital mental health | Improves title and account relevance where industry tagging is broad |
| Technologies, if relevant | Telehealth platforms, EHR-related keywords, patient engagement, behavioral health software | Useful when selling digital health or software solutions |
| Revenue range, if relevant | $1M–$10M; $10M–$50M; $50M–$250M; $250M+ | Segment smaller specialist practices versus enterprise health systems and major suppliers |
| Company type | Private; Public; Nonprofit; Academic; Government | Reflects the diverse attendee mix indicated by the official event description |
Suggested Apollo Search Logic: (“behavioral health” OR psychiatry OR “addiction medicine” OR “mental health” OR telepsychiatry OR “substance use disorder” OR recovery) AND (Medical Director OR “Director of Behavioral Health” OR “Director of Psychiatry” OR “Chief Medical Officer” OR “Program Director” OR “Research Director” OR “Clinical Director”) with geography prioritized to Massachusetts, Boston metro, Northeast U.S., and broader U.S. healthcare and academic institutions.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| GAB 2026 Official Event Website | Official event website | Confirmed event title, dates, hybrid format, venue name, address, Boston/Woburn location context, conference theme, audience profile, and scientific session topics | High |
| Hilton Boston/Woburn | Venue website | Venue identity and Woburn, Massachusetts location | High |
| Reviewed official website content supplied in prompt | Primary-source extract | Used as the primary source of truth for date, venue, city, state, country, hybrid format, and target audience description | High |
| Verification note | Research limitation | No current-year attendee count, exhibitor directory, sponsor directory, or named attendee organization list was verified in the reviewed official materials; any company-level outreach list should be validated with additional official pages before use. | High relevance limitation |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 7th Edition of Global Conference on Addiction Medicine, Behavioral Health and Psychiatry — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds